Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) today announces that it will be present at the following investor events during the second quarter of 2016:
- Gilbert Dupont Healthcare Conference – Paris, May 10, 2016
- Citi Swiss Healthcare Investor Day – Zurich, May 19-20, 2016
- Goldman Sachs 37th Annual Global Healthcare Conference – Rancho Palos Verdes, June 7-9, 2016
- Kepler Cheuvreux Biotech Days Conference – Paris, June 15-16, 2016
- Bryan Garnier 1st Oncology Day – Paris, June 17, 2016
- Citi European Healthcare Conference – London, June 21-22, 2016
- Société Générale CIB Healthcare & Biotechnology Conference – Paris, June 28, 2016
*****
The Company will host an Investor & Analyst Update on May 16th, 2016, in New York, USA, from 12:00 to 3:00 pm ET.
Innate Pharma’s management team will give an overview of the Company's pipeline of first-in-class monoclonal antibodies in Immuno-Oncology and provide an update on the Company's strategy.
The event is intended for institutional investors and sell-side analysts only. Please RSVP in advance if you plan to attend, as space is limited. To reserve a spot, please contact LifeSci Advisors, LLC at
mac@lifesciadvisors.com
*****
| PR in English | 71.97 KB |